Guselkumab, a medication with a mechanism of action that is new to inflammatory bowel disease (IBD) treatment, outperformed ...

Intravenous induction followed by subcutaneous maintenance therapy with guselkumab is efficacious for adults with moderately ...

Crohn’s disease (CD) is a chronic, progressive inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal (GI) tract—from the mouth to the anus. It most commonly affects the ...

A new study led by researchers at Mount Sinai Health System has identified distinct biological signatures in patients with ...

Ustekinumab is associated with a higher rate of clinical remission at 6 months compared with anti-TNF therapy among patients with CLDP. Ustekinumab may be more effective than anti-tumor necrosis ...

Pediatric hidradenitis suppurativa faces diagnostic delays and stigma, while adalimumab shows superior drug survival compared ...

Changes in sleep metrics detected with wearable technology could serve as an inflammation marker and potentially predict IBD ...

Several businesses opened or are opening soon in Flower Mound, Highland Village and Argyle. Keep reading for the latest ...

University of Birmingham medical student Nikhil Mistry gained a prestigious top prize at the 2025 Dr Falk Pharma/Guts UK ...

In this video, Joseph M. Runde, DO, attending physician in gastroenterology, hepatology and nutrition at Ann & Robert H. Lurie Children’s Hospital of Chicago and assistant professor of pediatrics at ...

Community for Crohn’s and Colitis Car Show returned to Port Crane today, raising money for those battling Crohn's and Colitis ...